Q-omics provides the consensus-scored CNOT4P1 profile across patient tissues and cancer cell-line models. CNOT4P1 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, CNOT4P1 is differentially expressed in 2, with the highest sampling consensus in HNSC. Additionally, CNOT4P1 RNA expression shows 6,342 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight UVM, HNSC, and STAD as cancer lineages where CNOT4P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for CNOT4P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes CNOT4P1 survival associations across molecular data types. CNOT4P1 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible CNOT4P1 RNA expression–survival associations across cancer types. High CNOT4P1 expression shows unfavorable associations in UVM, PAAD, UCS, OV, KIRC and MESO. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .006). Together, the overview and detailed table identify UVM as the clearest survival context for CNOT4P1 RNA expression.
This table summarizes CNOT4P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for CNOT4P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. CNOT4P1 shows higher tumor expression in HNSC and KIRC. The HNSC box plot shows higher CNOT4P1 RNA expression in tumor versus normal tissue (log2 FC = +0.042, t-test p = .024).
This table shows molecular features associated with CNOT4P1 in patient tissues and cancer cell lines. In patient samples, CNOT4P1 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
